Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by Ultrasound-Targeted microbubble destruction  by Chen, Shuyuan et al.
Cardiac Ultrasound
Optimization of Ultrasound Parameters
for Cardiac Gene Delivery of Adenoviral
or Plasmid Deoxyribonucleic Acid
by Ultrasound-Targeted Microbubble Destruction
Shuyuan Chen, MD,* Ralph V. Shohet, MD, FACC,* Raffi Bekeredjian, MD,*
Peter Frenkel, MD, FACC,*† Paul A. Grayburn, MD, FACC*†‡
Dallas, Texas
OBJECTIVES This study was undertaken to optimize echocardiographic parameters for successful gene
delivery to the heart and to extend the method from adenoviral to plasmid deoxyribonucleic
acid (DNA).
BACKGROUND We have previously shown that ultrasound-targeted microbubble destruction can direct tissue
expression of adenoviral transgenes to the heart. The optimal echocardiographic parameters
for this technique have not been reported.
METHODS Adenoviral or plasmid DNA encoding the luciferase reporter gene was incorporated into
liposome microbubbles and infused intravenously into anesthetized rats. We systematically
evaluated the effects of ultrasound parameters known to influence microbubble destruction,
including electrocardiogram (ECG) triggering, ultrasound frequency, mode of ultrasound,
and mechanical index, on gene expression in rat myocardium four days after treatment. In
addition, gene expression in heart, liver, and skeletal muscle were compared between
adenoviral and plasmid DNA.
RESULTS Optimal ultrasound parameters for this technique include low-transmission frequency (1.3
MHz), maximal mechanical index, and ECG triggering to allow complete filling of the
myocardial capillary bed by microbubbles. No difference was seen between ultraharmonics
and power Doppler mode. Using adenoviral DNA, optimal ultrasound parameters yielded
myocardial luciferase activity on the order of 104 relative light units/mg protein/min but with
even higher liver activity. Plasmid DNA was expressed in rat myocardium at similar levels but
without detectable liver expression.
CONCLUSIONS Ultrasound-targeted microbubble destruction can be used to deliver adenoviral or plasmid
DNA to the myocardium. This technique holds great promise in applying the rapidly
expanding repertoire of gene therapies being developed for cardiac disease. (J Am Coll
Cardiol 2003;42:301–8) © 2003 by the American College of Cardiology Foundation
A number of techniques have been proposed for gene
delivery to the heart, including intracoronary (1–4), intra-
pericardial (5,6), and direct myocardial injection (7–10). We
have previously demonstrated successful transfection of rat
myocardium in vivo by ultrasound-targeted microbubble
destruction (UTMD) of microbubbles containing an ade-
novirus encoding a beta-galactosidase reporter gene (11).
This study was undertaken to optimize echocardiographic
parameters for successful gene delivery using adenoviral and
plasmid deoxyribonucleic acid (DNA). We systematically
evaluated the effects of four ultrasound parameters that are
known to influence microbubble destruction, electrocardio-
gram (ECG) triggering, frequency, mode of ultrasound, and
mechanical index, on luciferase expression in rat myocar-
dium.
METHODS
Preparation of the adenovirus. AdCMV-luc is a recom-
binant, replication-defective adenovirus containing the fire-
fly luciferase cDNA under control of the strong cytomega-
lovirus promoter. AdCMV-luc was prepared as previously
described (12). Briefly, recombinant adenovirus was propa-
gated in human 911 cells. Infected cells were lysed 48 h after
infection with non-ionic detergent, and virus particles were
precipitated with polyethylene glycol and further purified by
CsCl density centrifugation and gel filtration. The concen-
trated virus was stored in Tris-buffered isotonic saline
containing 10% glycerol at 70°C.
Preparation of liposome microbubbles containing AdCMV-
luc or plasmid DNA. Liposome microbubbles were
prepared using a modification of a previously described
method (13). A solution of 0.4% 1,2-dipalmitoyl-sn-
glycero-3-phosphatidylcholine (Sigma Chemical Co., St.
Louis, Missouri), 0.1% 1,2-dipalmitoyl-sn-glycero-3-
phosphatidylethanolamine, (Sigma Chemical Co.), and
10% glycerol was mixed with AdCMV-luc solution (1 
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1012 pfu/ml) in a 2:1 ratio. Aliquots of 0.5 ml of this
solution were placed in 1.5-ml clear vials; the remaining
headspace was filled with the perfluoropropane gas (Air
Products, Inc, Allentown, Pennsylvania). Each vial was then
mechanically shaken for 20 s in a dental amalgamator
(Vialmix, Bristol-Myers Squibb Medical Imaging, N. Bil-
lerica, Massachusetts). The lipid-coated microbubbles ap-
pear as a milky-white suspension floating on the top of a
layer of liquid containing unattached AdCMV-luc. The
subnatant was discarded, and the microbubbles were washed
three times with phosphate-buffered saline to remove unat-
tached AdCMV-luc. The mean diameter and concentration
of the microbubbles in the upper layer were measured by
Coulter counter and were 1.9  0.4 m and 1.5  0.3 
109 bubbles/ml, respectively. The titer of AdCMV-luc
attached to the liposome microbubbles was 0.25  0.10 
1012 pfu/ml.
In similar fashion, plasmid DNA (1 to 10 mg) encoding
cytomegalovirus-luciferase was mixed into a 1-ml liposome
solution and incubated at 40°C for 30 min and then
transferred into vials containing perfluoropropane gas. The
vials were shaken mechanically for 20 s. The subnatant was
discarded, and the microbubble layer was washed three
times with phosphate-buffered saline to remove unattached
DNA. Deoxyribonucleic acid concentration of the micro-
bubbles was measured by optical density at a wavelength of
260, and integrity of the DNA was confirmed by gel
electrophoresis. Confocal microscopy using fluorescent-
labeled plasmid confirmed that the plasmid was incorpo-
rated into the phospholipid shell of the microbubbles.
Figure 1 shows the amount of DNA per milliliter of washed
microbubbles plotted against the initial amount of DNA in
the solution. The mean concentration of six different prep-
arations of microbubbles was 1.82  0.06  109 bubbles/
ml. At the saturation dose of 4 mg/ml, the amount of
plasmid DNA incorporated into the microbubble shell was
calculated to be 0.33 pg/microbubble.
Animal preparation. The study conformed to the “Posi-
tion of the American Heart Association on Research Ani-
mal Use.” Wild-type lean Zucker rats (250 to 350 g) were
anesthetized with ketamine and xylazine. A polyethylene
tube (P10) was inserted into the right jugular vein by
cutdown for intravenous infusion of microbubbles or control
solutions. A 20-min infusion of 1 ml of either AdCMV-
luc-microbubbles, microbubbles without AdCMV-luc, or
AdCMV-luc without microbubbles was administered. The
anterior chest was shaved, and echocardiography was per-
formed using an S12 transducer (Sonos 5500, Philips
Ultrasound, Andover, Massachusetts) to locate the heart
and record left ventricle (LV) function in a short-axis view.
During the infusion, an S3, S8, or S12 transducer was used
to target microbubble destruction to the heart using a clamp
to maintain its position and 1 to 2 cm of acoustic coupling
Abbreviations and Acronyms
AdCMV-luc  adenovirus encoding the luciferase gene
under a cytomegalovirus promoter
ANOVA  analysis of variance
DNA  deoxyribonucleic acid
ECG  electrocardiogram/electrocardiograph/
electrocardiographic
LV  left ventricle/ventricular
UTMD  ultrasound-targeted microbubble
destruction
Figure 1. Plot showing the amount of plasmid deoxyribonucleic acid (pDNA) that adheres to washed microbubbles (y-axis) as a function of the amount
of pDNA in the solution used to make the microbubbles. Roughly 15% of the DNA adheres to the microbubbles. The total amount of DNA attached to
the microbubbles appears to plateau at 4,000 g/ml of solution.
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gel between the transducer and the chest wall. After the
infusion, LV function was reassessed with the S12 trans-
ducer; the jugular vein was then tied off, and the skin was
closed. The rats were sacrificed four days later, and the liver
and hindlimb skeletal muscle were harvested as positive and
negative controls, respectively. The LV was isolated by
careful dissection then divided into anterior and posterior
sections, which were snap frozen with liquid nitrogen and
stored at 70°C until assayed.
Luciferase assay. To detect expression of the transgene,
the anterior and posterior LV sections, liver, and a section of
hindlimb skeletal muscles were pulverized with a mortar and
pestle and then disrupted with a Polytron in luciferase lysis
buffer (0.1% NP-40, 0.5% deoxycholate and proteinase
inhibitors, Promega Corporation, Madison, Wisconsin).
The resulting homogenate was centrifuged at 10,000 g for
10 min, and 100 l of luciferase reaction buffer (Promega)
was added to 20 l of the clear supernatant. Light emission
was measured by a luminometer (TD-20/20, Turner De-
signs Inc., Sunnyvale, California) in relative light units
(RLU)/min (14). Total protein content was determined by
a modification of the Lowry method (BCA protein assay
reagent, Pierce Biotechnology, Inc., Rockford, Illinois)(15).
Experimental protocols. The first set of experiments was
conducted to systemically evaluate the effects of several
ultrasound parameters that are known to effect microbubble
destruction on adenoviral gene expression using UTMD.
Four different parameters were tested in the following order:
ECG triggering, transducer frequency, mode of ultrasound,
and acoustic power. For each experiment, a minimum of
three rats for each group was tested.
To evaluate the effect of ECG triggering, continuous
ultrasound, which is highly destructive of microbubbles, was
compared with end-systolic–triggered ultrasound. The hy-
pothesis underlying this experiment was that triggered
ultrasound, by allowing complete replenishment of the
myocardial capillary bed between ultrasound bursts, would
allow greater gene expression than continuous ultrasound,
which would destroy microbubbles within the LV cavity
before they could enter the microcirculation. Triggered
ultrasound was performed with an S3 transducer operating
in ultraharmonic mode (transmit 1.3 MHz, receive 3.6
MHz) using a burst of four frames gated to every fourth
heartbeat at end-systole. This sequence produced the high-
est microbubble signal in the myocardium on the imaging
frame, with complete clearance of microbubbles at the end
of the burst. This is the same triggering sequence used in the
previous report of successful delivery of the beta-
galactosidase reporter gene to rat myocardium (11). Con-
tinuous ultrasound was performed at a frame rate of 33 ms
using otherwise-identical settings. For both groups, the
mechanical index was set at 1.6, depth at 3 cm, receive gain
at 50, and compression at 70, with a linear post-processing
curve.
The effect of different transducer frequencies on gene
delivery was assessed using three different transducers (S3,
S8, and S12) to deliver ultrasound at 1.3 MHz, 5 MHz, and
12 MHz, respectively. The hypothesis was that the lowest
frequency would provide superior gene expression because it
is more destructive of microbubbles. Other ultrasound
parameters were held constant, including the mechanical
index 1.6, depth 3 cm, gain 50, compression 70, and a linear
post-processing curve. Based on the results of the first
experiment, ECG triggering was used with four bursts of
ultrasound every fourth beat.
Next, ultraharmonic imaging, which transmits a single
pulse per scan line, was compared with power Doppler
imaging, which transmits multiple pulses per scan line.
Because multiple pulses should be more destructive than a
single pulse, we hypothesized that power Doppler imaging
would result in more effective gene delivery. Ultrasound
parameters were identical to those in the first experiment,
with end-systolic triggering of four bursts of ultrasound
every fourth heartbeat using the S3 transducer. The only
difference between groups was the use of triggered ultra-
harmonics versus triggered harmonic power Doppler.
The effect of acoustic power on gene delivery was com-
pared at mechanical index settings of 1.6 and 1.2 using the
S3 transducer. It is known that liposome microbubbles
disappear at both of these mechanical index settings. How-
ever, previous studies have shown that the mechanism of
destruction involves violent cavitation of the microbubbles
only at the maximal mechanical index. Therefore, we
hypothesized that gene expression would be higher at a
mechanical index of 1.6 than at 1.2. All other settings were
held constant as above. For all of the above experiments,
there were three rats in each group.
Delivery of plasmid DNA at different doses ranging from
1 to 8 mg/ml of microbubbles was tested using the optimal
ultrasound settings as determined from the above experi-
ments. In addition, the effect of increasing the mechanical
index from its usual maximal value of 1.6 to 2.0 on
expression of plasmid DNA was assessed. This was accom-
plished by manipulating the software within the ultrasound
system to drive the S3 transducer at a higher voltage than
normally allowed.
Statistical analysis. Differences in luciferase activity be-
tween experimental groups were compared by two-way
analysis of variance (ANOVA) using the experiment inter-
vention as one group and the tissue type (anterior myocar-
dium, posterior myocardium, liver, and skeletal muscle) as
the other group. A p value 0.05 was considered statisti-
cally significant. Post hoc Scheffe´ tests were performed only
when the ANOVA F values were statistically significant.
RESULTS
Triggered versus continuous ultrasound. The results are
illustrated in Figure 2. The difference between triggered and
continuous ultrasound was statistically significant (F 
23.9, p  0.0001), as was the difference between anterior
myocardium, posterior myocardium, liver, and skeletal mus-
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cle (F  80.1, p  0.0001). Liver activity was high (nearly
105 RLU/mg protein/min) for all infusions containing
AdCMV-luc and was significantly greater than myocardial
activity by Scheffe´ test (p  0.05). Luciferase activity in the
anterior wall (4.4  2.1  104 RLU/mg protein/min) was
approximately half that of liver activity and was twice that of
the posterior wall (2.0  0.7  104 RLU/mg protein/min)
with triggered ultrasound. Myocardial luciferase activity was
seen only with microbubbles containing AdCMV-luc in the
presence of ultrasound. No luciferase activity was detected
in control infusions or in skeletal muscle.
Ultrasound frequency. The results are shown in Figure 3.
Differences between frequencies (F  4.3, p  0.025) and
tissues (F  48.4, p  0.0001) were statistically significant.
Luciferase activity in the myocardium was inversely related
to ultrasound frequency. At the lowest frequency (1.3
MHz), luciferase activity in the anterior LV (3.8  0.2 
104 RLU/mg protein/min) was twice that of the posterior
wall (2.0  0.6  104 RLU/mg protein/min). At the
middle frequency, anterior wall luciferase activity was 5.9 
0.9 103 RLU/mg protein/min, with no significant activity
in the posterior wall (1.6  1.0  102 RLU/mg protein/
min). Again, there was no detectable luciferase activity
observed in skeletal muscle, and liver activity was high
(almost 105 RLU/mg protein/min) in all rats receiving
AdCMV-luc.
Ultraharmonics versus power Doppler. As shown in Fig-
ure 4, the difference between ultraharmonic and power
Doppler imaging modes was not statistically significant (F
 1.36, p  0.26). Again, luciferase activity in the anterior
LV is roughly half that of liver and twice that of the
posterior wall. These findings are consistent for all experi-
ments. The differences between tissues were statistically
significant (F  30.0, p  0.0001), primarily because of the
markedly high liver activity and absent skeletal muscle
activity.
Mechanical index. By ANOVA, there was a statistically
significant difference between a mechanical index of 1.6 and
1.2 (F  11.1, p  0.0049). In the anterior wall, luciferase
activity was sixfold higher at a mechanical index of 1.6 than
at 1.2 (2.4  1.6  104 vs. 0.4  0.3  104 RLU/mg
protein/min). In the posterior wall, luciferase activity was
1.6  0.7  104 RLU/mg protein/min at a mechanical
index of 1.6 but was barely detectable at a mechanical index
of 1.2.
Delivery of plasmid DNA. Experiments using plasmid
DNA were performed using the optimal echocardiographic
parameters determined from the previous experiments. Spe-
cifically, ECG triggering was performed at every fourth
end-systole using a transmission frequency of 1.3 MHz with
ultraharmonic mode and a mechanical index of 1.6. Figure
5 shows luciferase activity in the heart, liver, and skeletal
muscle. In the anterior wall, luciferase activity was 5.3 2.4
 103 RLU/mg/min at the highest dose compared with 3.8
 1.8  103 RLU/mg/min in the posterior wall with
Figure 2. Plot showing luciferase activity in skeletal muscle, liver, anterior myocardium, and posterior myocardium four days after delivery of microbubbles
containing adenovirus encoding the luciferase gene under a cytomegalovirus promoter (ADV) using ultrasound-targeted microbubble destruction. Triggered
ultrasound is shown in cross-hatched bars; continuous ultrasound in white bars. Control groups of rats receiving ADV without microbubbles (black bars)
and microbubbles without ADV (not shown due to no activity) are also included. Error bars show one standard deviation. US  ultrasound.
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virtually no expression in liver or skeletal muscle (F  19.7,
p  0.0001). In addition, the increase in luciferase activity
for the different doses of DNA per milliliter of micro-
bubbles was statistically significant (F  6.5, p  0.0015).
Figure 6 shows the effects of using a mechanical index
setting of 2.0 with plasmid DNA. At this mechanical index,
anterior wall luciferase activity was 1.2  0.2  104
RLU/mg/min compared with 5.2  1.4  103 RLU/mg/
min at a mechanical index of 1.6. Posterior wall activity was
roughly half that seen in the anterior wall (5.0  3.8  103
RLU/m/min and 2.0  0.9  103 RLU/m/min, respec-
tively) with no detectable liver or skeletal muscle activity. At
this ultrahigh mechanical index setting, plasmid luciferase
activity was on the same order of magnitude as that seen
with adenovirus at a mechanical index of 1.6. Importantly,
there were no significant ventricular arrhythmias or de-
creases in fractional area shortening at any of the mechanical
index settings in this study.
Figure 3. Plot showing luciferase activity (y-axis) in skeletal muscle, liver, anterior myocardium, and posterior myocardium at different ultrasound
transmission frequencies of 1.3 MHz (white bars), 5 MHz (cross-hatched bars), and 12 MHz (black bars). Error bars show one standard deviation. LV
left ventricle.
Figure 4. Plot showing luciferase activity (y-axis) in skeletal muscle, liver, anterior myocardium, and posterior myocardium during ultrasound-targeted
microbubble destruction using ultraharmonic mode (black bars) and harmonic power Doppler (white bars). Images were ECG triggered using a
transmission frequency of 1.3 MHz and mechanical index of 1.6. Error bars show one standard deviation. LV  left ventricle.
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DISCUSSION
These experiments demonstrate high levels of myocardial
luciferase activity after delivery of viral and plasmid trans-
genes using UTMD. Optimal expression was observed
using triggered ultrasound at a transmission frequency of 1.3
MHz and a high mechanical index. There was no significant
difference between ultraharmonic and power Doppler
modes. Using these optimal ultrasound settings, plasmid
DNA could be successfully delivered to rat myocardium
without the liver expression that limits the use of adenoviral
vectors (16). We consistently found higher expression in the
anterior than in the posterior wall, a finding most likely
explained by attenuation due to microbubbles in the LV
cavity.
Triggered versus continuous ultrasound. Because de-
struction of microbubbles is required for successful gene
delivery using UTMD, one might think that continuous
ultrasound (30 frames/s) would be superior to ECG-
Figure 5. Plot showing luciferase activity (y-axis) in skeletal muscle, liver, anterior myocardium, and posterior myocardium after ultrasound-targeted
microbubble destruction using plasmid deoxyribonucleic acid (pDNA) at different doses of DNA per microbubble solution. Error bars show one standard
deviation.
Figure 6. Plot showing luciferase activity (y-axis) in skeletal muscle, liver, anterior myocardium, and posterior myocardium after ultrasound-targeted
microbubble destruction using plasmid deoxyribonucleic acid at mechanical index settings of 1.6 (black bars) and 2.0 (white bars). Error bars show one
standard deviation. LV  left ventricle.
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triggered ultrasound. However, continuous ultrasound de-
stroys microbubbles within the LV cavity and myocardial
arterioles before they ever reach the capillary bed. In
addition, because myocardial capillary blood flow velocity is
slow (1 mm/s) (17), the capillary bed can never completely
fill with microbubbles during continuous ultrasound at
destructive acoustic pressure. This phenomenon has been
mathematically modeled by Wei et al. (18), who showed
that the ultrasound signal intensity rapidly rises and then
reaches a plateau when plotted against pulsing interval
during triggered ultrasound. The rate of rise corresponds to
blood flow velocity, and the plateau corresponds to capillary
blood volume. Thus, by using triggered ultrasound at
relatively long pulsing intervals, one can wait until the entire
myocardial capillary volume is filled with microbubbles
before destroying them. The present study confirms that
ECG triggering is superior to continuous ultrasound for
optimizing gene expression by UTMD.
Effect of frequency and ultrasound mode. Higher ultra-
sound frequencies have a higher axial resolution and yield
much better images, particularly in small animals such as
rodents. However, it is well known that lower frequencies
are more destructive of microbubbles (19,20). This study
confirms that much lower frequencies are required to
successfully deliver and express genes in the myocardium.
However, we were not able to control pulse duration, line
density, and beam width for the three different transducers.
For example, the pulse duration is longer for the S3
transducer, which would tend to increase microbubble
destruction. However, peak negative pressure and line
density are higher on the S8 and S12 transducers, which
would tend to offset the difference in pulse duration. Despite
these considerations, the differences in gene expression with
the S3 transducer were so large that we believe the conclu-
sion that lower frequencies are superior for UTMD remains
justified.
We also compared two imaging modalities: ultraharmon-
ics and power Doppler. We anticipated that power Doppler,
because it transmits multiple pulses per scan line, would be
superior to ultraharmonics. However, no significant differ-
ence was found, perhaps because both techniques resulted in
complete clearance of microbubbles from the myocardium
during each burst of ultrasound. This suggests that micro-
bubble destruction by both techniques was virtually com-
plete at a triggering interval every fourth cardiac cycle.
Effect of mechanical index. The finding that luciferase
expression was sixfold higher in the anterior myocardium at
a mechanical index of 1.6 than at 1.2 has important
implications regarding the mechanism of gene delivery and
expression by UTMD. At both settings, microbubbles were
destroyed, and visual clearance of microbubbles was com-
plete. However, recent studies from Ferrara’s laboratory
have shown that the mechanism of microbubble destruction
varies with the delivered acoustic pressure as well as micro-
bubble physical properties (21–23). At lower acoustic pres-
sures, gas diffusion out of the microbubble is enhanced, and
the microbubble dissolves over a period of milliseconds (24).
At maximal acoustic pressure, the microbubbles undergo
violent fragmentation over a period of nanoseconds due to
Raleigh-Taylor instability (24). Such rapid microbubble
collapse is known to generate a secondary shock wave
(25,26). Whether the fragmentation of the microbubble, the
secondary shock wave, or both, contribute to the transmis-
sion of adenoviral particles from the microbubble into the
surrounding tissues is not currently known. However, the
finding that maximal acoustic pressure results in higher
myocardial gene expression provides indirect evidence that
rapid microbubble fragmentation is necessary for efficient
gene delivery by UTMD. This finding is relevant not only
for establishing the appropriate ultrasound settings for
UTMD but also for engineering microbubbles specifically
designed for gene or drug delivery.
Comparison with other methods of adenoviral gene
delivery. Simple intracoronary injection of adenovirus does
not produce high levels of transgene expression (2–4).
However, temporary coronary occlusion or administration
of substances that increase vascular permeability have been
shown to increase the effectiveness of intracoronary infusion
of adenovirus. For example, Logeart et al. (4) demonstrated
myocardial luciferase activity with such interventions that
was roughly 10-fold lower than direct LV injection of
adenovirus in rabbits. The present study demonstrates high
levels of luciferase gene expression using systemic intrave-
nous infusion of AdCMV-luc-microbubbles during echo-
cardiography. Ultrasound-targeted microbubble destruction
directs gene delivery to specific organs with what we
anticipate will be substantial improvement in the therapeu-
tic ratio for a broad range of genetic manipulations. We did
not directly compare UTMD to more invasive methods of
gene delivery, such as direct LV injection or coronary
infusion, but the advantages of this much less invasive
approach in cardiac gene therapy are readily apparent.
Delivery of plasmid DNA. UTMD can successfully de-
liver plasmid DNA to myocardium. In these optimization
experiments, the levels of luciferase expression were similar
to that obtained using adenovirus but without the profound
liver uptake associated with adenovirus. This is the first
study to actually demonstrate successful expression of a
plasmid transgene using UTMD. Vannan et al. (27) re-
ported the expression of chloramphenicol acetyltransferase
using plasmid attached to the surface of cationic liposomes.
However, they did not achieve organ specificity, because the
levels of chloramphenicol acetyltransferase were similar in
the heart to organs that were not exposed to ultrasound. In
our study, there was no liver or skeletal muscle expression of
luciferase, indicating that UTMD can be used to achieve
organ specificity with plasmid DNA. Further studies are
needed to determine whether plasmid DNA expression in
the heart by UTMD can be enhanced by combining it with
other tissue-targeting strategies, such as manipulation of the
gene promoter or adding cell-specific ligands to the shell,
development of ultrasound transducers specifically designed
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for gene delivery, or improvements in microbubble shell
characteristics that allow more DNA to be loaded onto the
microbubbles.
Safety of UTMD. We have previously reported that
UTMD in rat hearts is associated with a small troponin T
leak without histologic evidence of inflammation or myo-
necrosis or echocardiographic evidence of LV dysfunction
(28). In this study, there was no evidence of LV dysfunction
by two-dimensional echocardiography; we did not measure
troponin T. However, we routinely use a 20-min infusion of
the microbubbles because in our early experience with the
technique, rapid bolus injections of contrast agent resulted
in profound LV dysfunction.
Conclusions. High levels of transgene expression can be
achieved in the heart using UTMD containing adenoviral or
plasmid DNA. Optimal ultrasound parameters for this
technique include a low-transmission frequency (1.3 MHz),
maximal mechanical index, and ECG triggering to allow
complete filling of the myocardial capillary bed by
microbubbles.
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